Full Paper Title: Superior progression-free survival with zanubrutinib plus rituximab vs bendamustine-rituximab in treatment-naïve mantle cell lymphoma (TN MCL): Primary analysis of a phase 3 study (MANGROVE)
Wang:

Disclosure:
Galapagos NV - Consultancy (Includes expert testimony); MSC National Research Institute of Oncology - Honoraria; Bristol Myers Squibb - Honoraria; Bristol Myers Squibb - Research Funding; Bristol Myers Squibb - Consultancy (Includes expert testimony); MJH Life Sciences - Honoraria; Gilead - Consultancy (Includes expert testimony); Genentech - Research Funding; Janssen - Consultancy (Includes expert testimony); Janssen - Research Funding; Mayo Clinic - Honoraria; Deciphera - Consultancy (Includes expert testimony); Loxo - Research Funding; Juno Therapeutics - Research Funding; Bioinvent - Consultancy (Includes expert testimony); Bioinvent - Honoraria; Bioinvent - Research Funding; AstraZeneca - Consultancy (Includes expert testimony); AstraZeneca - Research Funding; AstraZeneca - Honoraria; CAHON - Honoraria; Dava Oncology - Honoraria; Innocare - Research Funding; VJHemOnc - Honoraria; Kite Pharma - Honoraria; Kite Pharma - Consultancy (Includes expert testimony); Kite Pharma - Research Funding; Oncternal - Consultancy (Includes expert testimony); Oncternal - Research Funding; Molecular Templates - Research Funding; Nurix Therapeutics - Research Funding; South African Clinical Hematology Society - Honoraria; TG Therapeutics - Consultancy (Includes expert testimony); Amphista Therapeutics - Consultancy (Includes expert testimony); Catamount Medical Education - Honoraria; Pfizer - Consultancy (Includes expert testimony); Pfizer - Honoraria; East Virginia Medical School - Honoraria; Miltenyi Biotech - Consultancy (Includes expert testimony); Editorial Medica AWWE SA - Honoraria; Pharmacyclics - Research Funding; Parexcel - Consultancy (Includes expert testimony); Studio ER Congressi - Honoraria; Acerta Pharma - Research Funding; Acerta Pharma - Honoraria; Acerta Pharma - Consultancy (Includes expert testimony); Instituto Scientifico Romagnolo - Honoraria; Roche - Honoraria; Roche - Consultancy (Includes expert testimony); Roche - Research Funding; Vincerx - Research Funding; BeOne - Consultancy (Includes expert testimony); ADC Therapeutics - Consultancy (Includes expert testimony); ADC Therapeutics - Honoraria; Juno Therapeutics - Research Funding; Bantam Pharma - Research Funding; Pepromene Bio - Consultancy (Includes expert testimony); Be Biopharma - Consultancy (Includes expert testimony); Beigene - Consultancy (Includes expert testimony); Genentech - Research Funding; Physicians Education Resources (PER) - Honoraria; Physicians Education Resources (PER) - Consultancy (Includes expert testimony); NIH - Honoraria; Boxer Capital - Consultancy (Includes expert testimony); Binaytara Foundation - Honoraria; PromCon S.R.E - Honoraria; Scripps - Honoraria; Plexus Communications - Honoraria; Celgene - Research Funding; Merck - Consultancy (Includes expert testimony); Merck - Honoraria; Research to Practice - Honoraria; Genmab - Consultancy (Includes expert testimony); Genmab - Research Funding; Medscape/WebMD - Honoraria; AbbVie - Research Funding; AbbVie - Honoraria; AbbVie - Consultancy (Includes expert testimony); Lilly - Consultancy (Includes expert testimony); Lilly - Research Funding